NO162234C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere.Info
- Publication number
- NO162234C NO162234C NO830539A NO830539A NO162234C NO 162234 C NO162234 C NO 162234C NO 830539 A NO830539 A NO 830539A NO 830539 A NO830539 A NO 830539A NO 162234 C NO162234 C NO 162234C
- Authority
- NO
- Norway
- Prior art keywords
- acid esters
- preparation
- carboxyl acid
- therapeutic active
- active pyridine
- Prior art date
Links
- -1 PYRIDINE CARBOXYL Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
- Drawers Of Furniture (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823209274 DE3209274A1 (de) | 1982-03-13 | 1982-03-13 | Pyridincarbonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO830539L NO830539L (no) | 1983-09-14 |
| NO162234B NO162234B (no) | 1989-08-21 |
| NO162234C true NO162234C (no) | 1989-11-29 |
Family
ID=6158229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO830539A NO162234C (no) | 1982-03-13 | 1983-02-17 | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4705794A (fr) |
| EP (1) | EP0088940B1 (fr) |
| JP (1) | JPS58167571A (fr) |
| KR (1) | KR910000637B1 (fr) |
| AT (1) | ATE19875T1 (fr) |
| AU (1) | AU564367B2 (fr) |
| CA (1) | CA1208216A (fr) |
| DE (2) | DE3209274A1 (fr) |
| DK (1) | DK157857C (fr) |
| FI (1) | FI82687C (fr) |
| GR (1) | GR78454B (fr) |
| HU (1) | HU188851B (fr) |
| IE (1) | IE54879B1 (fr) |
| IL (1) | IL68095A (fr) |
| NO (1) | NO162234C (fr) |
| PH (1) | PH19685A (fr) |
| PT (1) | PT76328B (fr) |
| ZA (1) | ZA831691B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58185821U (ja) * | 1982-06-02 | 1983-12-10 | 日産自動車株式会社 | ウインドシ−ルド |
| DE4342196A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Neue 4-Phenyl-substituierte 1,4-Dihydropyridine |
| DE3410645A1 (de) * | 1984-03-23 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| GB8530602D0 (en) * | 1985-12-12 | 1986-01-22 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
| IT1204948B (it) * | 1987-03-13 | 1989-03-10 | Boheringer Biochemia Robin S P | 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono. |
| DE3712371A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung |
| DE3712369A1 (de) * | 1987-04-11 | 1988-10-27 | Bayer Ag | Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung |
| CA1312611C (fr) * | 1987-07-01 | 1993-01-12 | Yamanouchi Pharmaceutical Co., Ltd. | Derives pyridine, procede pour leur production et composition pharmaceutique en contenant |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| EP0657432B1 (fr) * | 1993-12-10 | 2003-03-12 | Bayer Ag | 1,4-Dihydropyridines substitués par un groupement phényle avec une activité cérébrale |
| DE4430639A1 (de) | 1994-08-29 | 1996-03-07 | Bayer Ag | Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten |
| WO2005025507A2 (fr) * | 2003-09-10 | 2005-03-24 | Synta Phamaceuticals Corp. | Composes de dihydropyridine permettant de traiter ou de prevenir des troubles metaboliques |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3209276A1 (de) * | 1982-03-13 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | Arzneimittel mit antihypoxischer und ischaemie-protektiver wirkung |
-
1982
- 1982-03-13 DE DE19823209274 patent/DE3209274A1/de not_active Withdrawn
-
1983
- 1983-02-17 NO NO830539A patent/NO162234C/no unknown
- 1983-02-28 US US06/470,886 patent/US4705794A/en not_active Expired - Fee Related
- 1983-03-02 DE DE8383102001T patent/DE3363581D1/de not_active Expired
- 1983-03-02 EP EP83102001A patent/EP0088940B1/fr not_active Expired
- 1983-03-02 AT AT83102001T patent/ATE19875T1/de active
- 1983-03-03 PT PT76328A patent/PT76328B/pt unknown
- 1983-03-07 AU AU12081/83A patent/AU564367B2/en not_active Ceased
- 1983-03-10 FI FI830810A patent/FI82687C/fi not_active IP Right Cessation
- 1983-03-10 IL IL68095A patent/IL68095A/xx unknown
- 1983-03-11 CA CA000423460A patent/CA1208216A/fr not_active Expired
- 1983-03-11 GR GR70766A patent/GR78454B/el unknown
- 1983-03-11 HU HU83847A patent/HU188851B/hu not_active IP Right Cessation
- 1983-03-11 PH PH28638A patent/PH19685A/en unknown
- 1983-03-11 ZA ZA831691A patent/ZA831691B/xx unknown
- 1983-03-11 JP JP58039303A patent/JPS58167571A/ja active Granted
- 1983-03-11 KR KR1019830000979A patent/KR910000637B1/ko not_active IP Right Cessation
- 1983-03-11 IE IE535/83A patent/IE54879B1/en not_active IP Right Cessation
- 1983-03-11 DK DK117783A patent/DK157857C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT76328A (en) | 1983-04-01 |
| FI82687B (fi) | 1990-12-31 |
| DK157857C (da) | 1990-07-30 |
| FI82687C (fi) | 1991-04-10 |
| HU188851B (en) | 1986-05-28 |
| NO830539L (no) | 1983-09-14 |
| PH19685A (en) | 1986-06-13 |
| DK157857B (da) | 1990-02-26 |
| FI830810A0 (fi) | 1983-03-10 |
| JPS58167571A (ja) | 1983-10-03 |
| KR910000637B1 (ko) | 1991-01-31 |
| DE3363581D1 (en) | 1986-06-26 |
| AU564367B2 (en) | 1987-08-13 |
| GR78454B (fr) | 1984-09-27 |
| DK117783A (da) | 1983-09-14 |
| EP0088940A1 (fr) | 1983-09-21 |
| NO162234B (no) | 1989-08-21 |
| PT76328B (en) | 1985-11-11 |
| DE3209274A1 (de) | 1983-09-15 |
| IE54879B1 (en) | 1990-03-14 |
| ZA831691B (en) | 1983-12-28 |
| AU1208183A (en) | 1983-09-15 |
| DK117783D0 (da) | 1983-03-11 |
| KR840004079A (ko) | 1984-10-06 |
| US4705794A (en) | 1987-11-10 |
| ATE19875T1 (de) | 1986-06-15 |
| CA1208216A (fr) | 1986-07-22 |
| FI830810L (fi) | 1983-09-14 |
| EP0088940B1 (fr) | 1986-05-21 |
| IE830535L (en) | 1983-09-13 |
| JPH0551581B2 (fr) | 1993-08-03 |
| IL68095A (en) | 1986-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK114783A (da) | Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
| NO162234C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere. | |
| FI831604A0 (fi) | Pyridinderivat, deras framstaellning och anvaendning | |
| SE7607566L (sv) | Forfarande for framstellning av 1,4-dihydropyridinderivat | |
| DK57492D0 (da) | Farmaceutiske praeparater af n-phenylbenzamidderivater | |
| DK159148C (da) | Analogifremgangsmaade til fremstilling af tranexamsyrederivater | |
| NO862621D0 (no) | Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater. | |
| SE8204893D0 (sv) | Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| DK359387D0 (da) | Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling | |
| NO164978C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaryloxy-beta-carbolinderivater. | |
| DE3363248D1 (en) | Use of pyridine compounds for the manufacture of medicaments with an antihypoxemia and ischemia-protective activity | |
| FI924934A0 (fi) | Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning | |
| FI823278L (fi) | Foerfarande foer framstaellning av nya triazolokinazoloner och deras salter | |
| ES8100282A1 (es) | Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina | |
| NO165106C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aminoalkyl-beta-carbolinderivater. | |
| NO930844L (no) | 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater | |
| NO152252C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av 4-(n-(substituert-benzyliden)aminometyl)-cykloheksan-1-karboksylsyre | |
| DE2963724D1 (en) | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them |